Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of iptacopan in generalized myasthenia gravis
jRCT2031240321Phase 3Recruiting
- Sponsor
- Novartis
- Start
- Sep 2024
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in myasthenia gravis (MG) comparing Iptacopan arm with Placebo arm (2 arms). Started Sep 2024; status: recruiting.
02
Drugs
Iptacopan
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on jRCT2031240321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240321.